Immediate Impact
1 by Nobel laureates 1 from Science/Nature 52 standout
Citing Papers
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
2024 Standout
Towards targeting the breast cancer immune microenvironment
2024 Standout
Works of S. Loibl being referenced
PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S. Loibl | 249 | 221 | 120 | 141 | 29 | 499 | |
| M. Combe | 221 | 174 | 76 | 103 | 20 | 430 | |
| Edmonson Jh | 246 | 197 | 157 | 99 | 27 | 560 | |
| Mignon-Denise Keyver-Paik | 249 | 139 | 79 | 138 | 30 | 536 | |
| A. Bamias | 222 | 181 | 117 | 129 | 27 | 549 | |
| Seyran Yiğit | 179 | 93 | 83 | 72 | 41 | 418 | |
| Lingfang Xia | 160 | 166 | 50 | 86 | 33 | 457 | |
| Ying L. Liu | 188 | 122 | 64 | 75 | 45 | 419 | |
| Grazia Artioli | 162 | 200 | 119 | 100 | 37 | 546 | |
| Anna Maria Mosconi | 348 | 128 | 88 | 69 | 38 | 538 | |
| Todd Sheridan | 218 | 133 | 221 | 127 | 24 | 528 |
All Works
Loading papers...